Abstract
Inductively coupled plasma analysis of soybean Bowman–Birk inhibitor (BBI) indicated that BBI was a metalloprotein which contained magnesium, calcium, and zinc at 0.40, 0.43 and 0.008 atom/mol BBI, respectively. Heparin-enhanced gelatin zymography, quenched fluorescence substrate hydrolysis analysis, and the Biotrak assay of the interaction of BBI with the matrix metalloproteinase-1 (MMP-1) demonstrated that demineralized BBI at 30 nm inhibited MMP-1 activity whereas mineralized BBI was inhibitory at 115 nm.
Similar content being viewed by others
References
Arihiro S, Ohtani H, Hiwatashi N, Torii A, Sorsa T, Nagura H (2001) Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease. Histopathology 39: 50–59.
Armstrong, WB, Kennedy AR, Wan SX, Taylor TH, Nguyen QA, Jensen J, Thompson W, Lagerberg W, Meyskens Jr. FL (2000) Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin. Cancer Res. 6: 4684–4691.
Birk Y (1985) The Bowman-Birk inhibitor. Trypsin-and chymotrypsin-inhibitor from soybeans. Int. J. Pept. Protein Res. 25: 113–131.
Brandon DL, Bates AH, Friedman M (1991) ELISA analysis of soybean trypsin inhibitors in processed foods. Adv. Exp. Med. Biol. 289: 321–337.
Cohen SL, Chait BT (1997) Mass spectrometry of whole proteins eluted from solution dodecyl sulfate-polyacrylamide gel electrophoresis gels. Anal. Biochem. 247: 257–267.
Duncan ME, Richardson JP, Murray GI, Melvin WT, Fothergill JE (1998) Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. Eur. J. Biochem. 258: 37–43.
Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O (2002) Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95: 1902–1910.
Kennedy AR (1998) Chemopreventive agents: protease inhibitors. Pharmacol Ther. 78: 167–209.
Knight CG, Willenbrock F, Murphy G (1992) A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296: 263–266.
Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63: 1138–1143.
Liener IE (1994) Implications of antinutritional components in soybean foods. Crit. Rev. Food Sci. Hum. Nutr. 34: 31–67.
Lippman SM, Matrisian, LM (2000) Protease inhibitors in oral carcinogenesis and chemoprevention. Clin Cancer Res. 6: 4599–4603.
Scappaticci FA (2002) Mechanisms and future directions for angiogenesis-based cancer therapies. J. Clin. Oncol. 18: 3906–3927.
Somerville RPT, Oblander SA, Apte SS (2003) Matrix metalloproteinase: old dogs with new tricks. Genome Biol. 4: 216.
Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, Tsuruo T, Shibata Y, Muto T, Nagawa H (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 5: 108–114.
Wary KK, Thakker GD, Humtsoe JO, Yang J (2003) Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol. Cancer 2: 25–36.
Yen JT, Jensen AH, Simon J (1977) Effect of dietary raw soybean and soybean trypsin inhibitor on trypsin and chymotrypsin activities in the pancreas and in small intestinal juice of growing swine. J. Nutr. 107: 156–165.
Yu WH, Woessner Jr. JF (2001) Heparin-enhanced zymographic detection of matrilysin and collagenases. Anal Biochem. 293: 38–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Losso, J.N., Munene, C.N., Bansode, R.R. et al. Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman–Birk inhibitor. Biotechnology Letters 26, 901–905 (2004). https://doi.org/10.1023/B:bile.0000025900.33812.7c
Issue Date:
DOI: https://doi.org/10.1023/B:bile.0000025900.33812.7c